Pentoxifylline: not just for alcoholic hepatitis anymore? Roman E. PerriVijay H. Shah Editorial 08 April 2008 Pages: 137 - 139
Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B Teerha Piratvisuth Review Article 04 March 2008 Pages: 140 - 146
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure Stephen Locarnini Review Article 28 March 2008 Pages: 147 - 151
Hepatitis B reactivation after chemotherapy: two decades of clinical research George K. K. Lau HBV (Clinical & Basic) 05 March 2008 Pages: 152 - 162
Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues Nancy Leung Review Article 04 March 2008 Pages: 163 - 178
Should chronic HBV infected patients with normal ALT treated: debate Shiv Kumar SarinManoj Kumar Review article 04 March 2008 Pages: 179 - 184
Chronic HBV infection with persistently normal ALT b. not to treat Kwang-Hyub HanDo Young Kim Others (Announcements, etc.) 06 March 2008 Pages: 185 - 189
Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors Wing-Kin SynPeter NightingaleJeffrey M. Bateman Original Article 28 February 2008 Pages: 190 - 195
A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH) Yin-Mei LeeDede S. SutedjaSeng-Gee Lim NASH (NAFLD), PHT, Hepatic Failure and Others 28 February 2008 Pages: 196 - 201
Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease Payal BhardwajKaushal MadanAnoop Saraya NASH (NAFLD), PHT, Hepatic Failure and Others 27 February 2008 Pages: 202 - 208
Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report S. RajindrajithA. S. DassanayakeH. J. de Silva NASH (NAFLD), PHT, Hepatic Failure and Others 27 February 2008 Pages: 209 - 212
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis Norimasa MiuraHiroko KabashimaGoshi Shiota ORIGINAL ARTICLE 09 April 2008 Pages: 213 - 221
Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers Minoru NakamuraKenji FunamiTsukasa Seya Original Article 26 March 2008 Pages: 222 - 230
Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India Shashi Bala PaulVishnubhatla SreenivasSubrat Kumar Acharya Original Article 27 February 2008 Pages: 231 - 236
Prognostic analysis of pulmonary metastases from hepatocellular carcinoma Shu-Min ZhangZhao-Chong ZengBo-Heng Zhang Original Article 15 March 2008 Pages: 237 - 243
Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV) Hie-Won HannHee Bok ChaeStephen R. Dunn Original Article 28 February 2008 Pages: 244 - 249
Metabolic profiles in patients with chronic hepatitis C: a case–control study Ching-Sheng HsuChun-Jen LiuJia-Horng Kao Original Article 28 February 2008 Pages: 250 - 257
Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver Tetsuro SohdaTakayuki HananoShotaro Sakisaka Case Report Open access 08 April 2008 Pages: 258 - 261